21 provinces!

Following the 19 provinces and cities shared before, on September 28, Fujian and Zhejiang provinces also announced the specific bid execution time

In addition, Shanghai, which previously announced that the bid will be executed in late October, has also specified in the latest notice from the Shanghai Municipal Medical Insurance Bureau that the bid execution time is October 20

So far, 21 provinces and cities have announced the date of bid execution nationwide.

Fujian Province

On September 28, the Fujian Provincial Medical Insurance Bureau and the Fujian Provincial Health Commission issued the "Notice on Implementing the Fifth Batch of National Organizations for Centralized Procurement and Use of Drugs", announcing that the fifth batch of nationally selected 61 selected varieties will be held in October 2021.

The "Notice" requires that, in principle, the proportion of selected drugs purchased during the procurement cycle should not be lower than that of non-selected drugs with the same generic name

The selected drugs are sold at a zero markup rate, and the sales price within the scope of the medical insurance catalogue is used as the medical insurance payment standard

In the non-competitive group with the same generic name, except for the selected drugs, if the actual purchase price is lower than or equal to the original maximum sales limit, the actual purchase price shall be sold at zero markup; if the actual purchase price is higher than the original maximum sales limit, the original maximum Sales limit sales

If the sales price is higher than the selected price, the first year will reduce the sales price by 30% to determine the medical insurance payment standard.

For drugs in the competition group with the same generic name, the maximum selling price shall be determined at the price not exceeding the selected price, and the maximum selling price shall be the medical insurance payment standard

Zhejiang Province

On September 28, the Zhejiang Provincial Medical Insurance Bureau issued the "Announcement on the Implementation of the Results of the Fifth Batch of National-Organized Drug Centralized Procurement", announcing the implementation of the fifth batch of national-selected results from October 20, 2021

The scope of medicines includes the fifth batch of nationally selected drugs, and according to the "Notice on the Implementation of the Fifth Batch of National Organizations for Drug Centralized Procurement of Incomplete Specification Price Linkage", the inquired esomeprazole sodium 20mg and isonitrate for injection are required to be successfully inquired.

Shanghai

On September 23, the Shanghai Municipal Medical Insurance Bureau, in conjunction with the Shanghai Municipal Health Commission and the Food and Drug Administration, issued the "Notice on Doing a Good Job in the Fifth Batch of State-Organized Drug Centralized Procurement and Use of Drugs in this Municipality", which also clarified when the bid will be implemented.

The "Notice" requires priority purchase and use of selected drugs, and encourages non-selected drugs to actively reduce their prices

If the original city-winning drug (or drug listed on the Internet) with the same generic name (including dosage form) as the selected drug is not eligible, but the quality and efficacy are guaranteed, and the price is reasonable, the medical institution can choose the drug in the prerequisite for priority procurement Continue to purchase, in principle, the quantity shall not exceed the selected drugs

Medical institutions should give full play to the role of clinical pharmacists, strengthen prescription review and prescription reviews of medical institutions, and further strengthen the assessment of rational drug use